Literature DB >> 33514590

Understanding abortion-related complications in health facilities: results from WHO multicountry survey on abortion (MCS-A) across 11 sub-Saharan African countries.

Zahida Qureshi1, Hedieh Mehrtash2, Seni Kouanda3, Sally Griffin4, Veronique Filippi5, Philip Govule6, Soe Soe Thwin2, Folasade Adenike Bello7, Luis Gadama8, Ausbert Thoko Msusa9, Nafiou Idi10, Sourou Goufodji11, Caron Rahn Kim2, Jean-Jose Wolomby-Molondo12, Kidza Yvonne Mugerwa13, Cassimo Bique14, Richard Adanu15, Bukola Fawole7, Thierry Madjadoum16, Ahmet Metin Gülmezoglu2, Bela Ganatra2, Özge Tunçalp2.   

Abstract

INTRODUCTION: Complications due to unsafe abortions are an important cause of morbidity and mortality in many sub-Saharan African countries. We aimed to characterise abortion-related complication severity, describe their management, and to report women's experience of abortion care in Africa.
METHODS: A cross-sectional study was implemented in 210 health facilities across 11 sub-Saharan African countries. Data were collected on women's characteristics, clinical information and women's experience of abortion care (using the audio computer-assisted self-interviewing (ACASI) system). Severity of abortion complications were organised in five hierarchical mutually exclusive categories based on indicators present at assessment. Descriptive bivariate analysis was performed for women's characteristics, management of complications and reported experiences of abortion care by severity. Generalised linear estimation models were used to assess the association between women's characteristics and severity of complications.
RESULTS: There were 13 657 women who had an abortion-related complication: 323 (2.4%) women were classified with severe maternal outcomes, 957 (7.0%) had potentially life-threatening complications, 7953 (58.2%) had moderate complications and 4424 (32.4%) women had mild complications. Women who were single, multiparous, presenting ≥13 weeks of gestational age and where expulsion of products of conception occurred prior to arrival to facility were more likely to experience severe complications. For management, the commonly used mechanical methods of uterine evacuation were manual vacuum aspiration (76.9%), followed by dilation and curettage (D&C) (20.1%). Most frequently used uterotonics were oxytocin (50∙9%) and misoprostol (22.7%). Via ACASI, 602 (19.5%) women reported having an induced abortion. Of those, misoprostol was the most commonly reported method (54.3%).
CONCLUSION: There is a critical need to increase access to and quality of evidence-based safe abortion, postabortion care and to improve understanding around women's experiences of abortion care. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  cross-sectional survey; epidemiology; obstetrics

Mesh:

Year:  2021        PMID: 33514590      PMCID: PMC7845704          DOI: 10.1136/bmjgh-2020-003702

Source DB:  PubMed          Journal:  BMJ Glob Health        ISSN: 2059-7908


  37 in total

1.  The epidemiology of incomplete abortion in South Africa. National Incomplete Abortion Reference Group.

Authors:  H Rees; J Katzenellenbogen; R Shabodien; R Jewkes; S Fawcus; J McIntyre; C Lombard; H Truter
Journal:  S Afr Med J       Date:  1997-04

Review 2.  High-quality health systems in the Sustainable Development Goals era: time for a revolution.

Authors:  Margaret E Kruk; Anna D Gage; Catherine Arsenault; Keely Jordan; Hannah H Leslie; Sanam Roder-DeWan; Olusoji Adeyi; Pierre Barker; Bernadette Daelmans; Svetlana V Doubova; Mike English; Ezequiel García-Elorrio; Frederico Guanais; Oye Gureje; Lisa R Hirschhorn; Lixin Jiang; Edward Kelley; Ephrem Tekle Lemango; Jerker Liljestrand; Address Malata; Tanya Marchant; Malebona Precious Matsoso; John G Meara; Manoj Mohanan; Youssoupha Ndiaye; Ole F Norheim; K Srinath Reddy; Alexander K Rowe; Joshua A Salomon; Gagan Thapa; Nana A Y Twum-Danso; Muhammad Pate
Journal:  Lancet Glob Health       Date:  2018-09-05       Impact factor: 26.763

3.  The Imperative to Expand Provision, Access and Use of Misoprostol for Post-Abortion Care in sub-Saharan Africa.

Authors:  Andrzej Kulczycki
Journal:  Afr J Reprod Health       Date:  2016-09

4.  Availability, accessibility and utilization of post-abortion care in Sub-Saharan Africa: A systematic review.

Authors:  Chimaraoke Izugbara; Frederick Murunga Wekesah; Meroji Sebany; Elizabeth Echoka; Joshua Amo-Adjei; Winstoun Muga
Journal:  Health Care Women Int       Date:  2019-12-19

5.  Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study.

Authors:  João Paulo Souza; Ahmet Metin Gülmezoglu; Joshua Vogel; Guillermo Carroli; Pisake Lumbiganon; Zahida Qureshi; Maria José Costa; Bukola Fawole; Yvonne Mugerwa; Idi Nafiou; Isilda Neves; Jean-José Wolomby-Molondo; Hoang Thi Bang; Kannitha Cheang; Kang Chuyun; Kapila Jayaratne; Chandani Anoma Jayathilaka; Syeda Batool Mazhar; Rintaro Mori; Mir Lais Mustafa; Laxmi Raj Pathak; Deepthi Perera; Tung Rathavy; Zenaida Recidoro; Malabika Roy; Pang Ruyan; Naveen Shrestha; Surasak Taneepanichsku; Nguyen Viet Tien; Togoobaatar Ganchimeg; Mira Wehbe; Buyanjargal Yadamsuren; Wang Yan; Khalid Yunis; Vicente Bataglia; José Guilherme Cecatti; Bernardo Hernandez-Prado; Juan Manuel Nardin; Alberto Narváez; Eduardo Ortiz-Panozo; Ricardo Pérez-Cuevas; Eliette Valladares; Nelly Zavaleta; Anthony Armson; Caroline Crowther; Carol Hogue; Gunilla Lindmark; Suneeta Mittal; Robert Pattinson; Mary Ellen Stanton; Liana Campodonico; Cristina Cuesta; Daniel Giordano; Nirun Intarut; Malinee Laopaiboon; Rajiv Bahl; Jose Martines; Matthews Mathai; Mario Merialdi; Lale Say
Journal:  Lancet       Date:  2013-05-18       Impact factor: 79.321

6.  WHO Multi-Country Survey on Abortion-related Morbidity and Mortality in Health Facilities: study protocol.

Authors:  Caron R Kim; Özge Tunçalp; Bela Ganatra; Ahmet Metin Gülmezoglu
Journal:  BMJ Glob Health       Date:  2016-11-25

7.  How women are treated during facility-based childbirth in four countries: a cross-sectional study with labour observations and community-based surveys.

Authors:  Meghan A Bohren; Hedieh Mehrtash; Bukola Fawole; Thae Maung Maung; Mamadou Dioulde Balde; Ernest Maya; Soe Soe Thwin; Adeniyi K Aderoba; Joshua P Vogel; Theresa Azonima Irinyenikan; A Olusoji Adeyanju; Nwe Oo Mon; Kwame Adu-Bonsaffoh; Sihem Landoulsi; Chris Guure; Richard Adanu; Boubacar Alpha Diallo; A Metin Gülmezoglu; Anne-Marie Soumah; Alpha Oumar Sall; Özge Tunçalp
Journal:  Lancet       Date:  2019-10-08       Impact factor: 79.321

8.  Overview of abortion cases with severe maternal outcomes in the WHO Multicountry Survey on Maternal and Newborn Health: a descriptive analysis.

Authors:  M Dragoman; W R Sheldon; Z Qureshi; J Blum; B Winikoff; B Ganatra
Journal:  BJOG       Date:  2014-03       Impact factor: 6.531

9.  The WHO maternal near-miss approach and the maternal severity index model (MSI): tools for assessing the management of severe maternal morbidity.

Authors:  Joao Paulo Souza; Jose Guilherme Cecatti; Samira M Haddad; Mary Angela Parpinelli; Maria Laura Costa; Leila Katz; Lale Say
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

Review 10.  Women's Awareness and Knowledge of Abortion Laws: A Systematic Review.

Authors:  Anisa R Assifi; Blair Berger; Özge Tunçalp; Rajat Khosla; Bela Ganatra
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

View more
  2 in total

1.  What's needed to improve safety and quality of abortion care: reflections from WHO/HRP Multi-Country Study on Abortion across the sub-Saharan Africa and Latin America and Caribbean regions.

Authors:  Hedieh Mehrtash; Caron Rahn Kim; Bela Ganatra; Özge Tuncalp
Journal:  BMJ Glob Health       Date:  2021-08

2.  Preventing death following unsafe abortion: a case series from urban Uganda.

Authors:  Imelda Namagembe; Annettee Nakimuli; Josephat Byamugisha; Ashley Moffett; Abigail Aiken; Catherine Aiken
Journal:  AJOG Glob Rep       Date:  2022-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.